Brian Freeman, MD

Dr. Freeman is an entrepreneur, physician, and co-founder of Energesis. He previously served as a Venture Partner at GreatPoint Ventures. While at GreatPoint he co-founded Zafgen, a venture-backed company that pioneered the development of MetAP2 inhibitors for obesity and became publicly traded in 2014. He has prior experience in biopharmaceutical management consulting at SVB Leerink, where he advised pharmaceutical and biotechnology companies on strategic acquisitions, in-licensing, pipeline prioritization, and clinical development. Dr. Freeman is board-certified in neurology, having trained at the University of Pennsylvania, obtained his medical degree and Masters in Molecular Cell Biology from Washington University in St. Louis, and completed his undergraduate studies at MIT.